Welcome to our dedicated page for MODEL N news (Ticker: MODN), a resource for investors and traders seeking the latest updates and insights on MODEL N stock.
Model N, Inc. (NYSE: MODN) is a leader in cloud-based revenue management solutions that transform complex business processes into streamlined operations. The company’s mission is to drive essential business processes such as configure, price, and quote (CPQ), contract and rebate management, business intelligence, and regulatory compliance. This transformation is achieved by turning the revenue lifecycle from a series of disconnected operations into a cohesive, end-to-end strategic process.
Model N caters to life sciences, technology, and manufacturing industries, providing solutions that meet the complex needs of some of the world's leading brands, including Johnson & Johnson, AstraZeneca, Boston Scientific, Novartis, Microchip Technology, and ON Semiconductor. Its offerings are utilized in over 100 countries, ensuring robust global reach and impact.
The company's flagship products include the Revenue Cloud for Life Sciences and the Revenue Cloud for High Tech. These platforms are designed to enhance revenue and operational efficiency while complying with stringent regulatory requirements. They enable the creation and execution of contracts, modernize sales processes, and strategically manage the revenue lifecycle.
Model N has recently launched Price Management, a new solution aimed at semiconductor, electronic component, and high-tech manufacturers to manage price execution across various sales channels globally. This solution integrates with Model N's Deal Management to provide a comprehensive pricing update system, ensuring real-time data alignment with market realities and regulatory compliance.
Additionally, the company's 2024 State of Revenue Report highlights the priorities and challenges faced by executives in pharmaceutical, medical technology, and high-tech manufacturing sectors. Key findings include the emphasis on advanced analytics and AI to improve process efficiency and cost-saving measures, while addressing issues like supply chain disruptions and regulatory changes.
Model N is currently undergoing a significant transition, with a pending acquisition by Vista Equity Partners, announced in April 2024. Despite this, the company remains focused on its core mission, providing innovative solutions to drive revenue optimization and compliance for its esteemed clientele.
For more information, visit www.modeln.com.
Model N plans to announce its financial results for the second quarter of fiscal year 2022 on May 10, 2022, after market close. The company will host a conference call at 2:00 p.m. PT (5:00 p.m. ET) on the same day to discuss these results and its business outlook. A live webcast will be available on the investor relations page of Model N's website, with a replay accessible until May 24, 2022.
Model N, Inc. (NYSE: MODN) successfully wrapped up its 18th annual Rainmaker22 conference, attracting over 700 industry executives and experts. The event showcased the new Model N 3.0 solution portfolio and introduced Model N Ngage, enhancing user experience with tailored in-app guidance. The 2022 State of Revenue Report highlighted key industry trends, revealing that 73% of revenue management professionals prefer partners offering software and expert services. Model N's innovative approach pairs technology with expertise, addressing ongoing challenges in revenue management and compliance.
Model N, Inc. (NYSE: MODN) released its 2022 State of Revenue Report, highlighting significant challenges in revenue management due to supply chain disruptions (44%), AI integration (40%), and staffing issues (98%). Notably, 99% of executives acknowledged the need for enhanced technology capabilities to optimize revenue processes. Despite a decline in pandemic-related concerns (37%), regulatory compliance remains a top issue for 81% of life sciences executives. The report reflects ongoing demands for innovative revenue management solutions in challenging market conditions.
Model N, a leader in cloud revenue management solutions, will have CEO Jason Blessing and CFO John Ederer present at the JMP Securities Technology Conference on March 8, 2022, at 8:30 a.m. PT (11:30 a.m. ET). The event will be accessible via webcast on Model N's investor relations page. As a trusted provider for over 120 countries, Model N offers integrated solutions for life sciences and high tech companies, helping to minimize revenue leakage and enhance operational efficiency.
Model N (NYSE: MODN) reported a 21% year-over-year revenue growth for Q1 FY2022, totaling $51.5 million. The subscription revenue also increased 21% to $38.1 million. Despite strong performance, the GAAP net loss widened to $(6.3) million, compared to $(5.2) million in Q1 FY2021. Gross profit rose 13% to $28.9 million, but gross margin declined to 56%. The company provided guidance for Q2 FY2022 with expected total revenues between $51.0 million and $51.5 million.
Model N, Inc. (NYSE: MODN) announces the launch of its new State Price Transparency Management (SPTM) SaaS solution aimed at aiding pharmaceutical and biotech companies in meeting state price transparency mandates. The solution automates compliance processes, ensuring traceability and standardization. Key features include legislative and reporting templates, a scheduled reports calendar, and analytical tools for assessing price impacts. This initiative reflects Model N's commitment to support life sciences firms in adapting to evolving regulatory demands.
Model N, Inc. (NYSE: MODN) announced that Alex Azar, former U.S. Secretary of Health and Human Services, will keynote its Rainmaker22 conference from March 21-23, 2022. This annual event focuses on revenue management innovation in life sciences and high-tech industries. Azar will share insights from his healthcare experience, emphasizing lessons learned during the COVID-19 pandemic. Rainmaker22 aims to unite leaders to discuss how Model N's cloud solutions enhance business growth and minimize revenue leakage, featuring 44 sessions led by industry experts.
GE has appointed Scott Reese as the new CEO of GE Digital, effective February 22, 2022, succeeding Patrick Byrne. Reese, previously with Autodesk, brings extensive experience in product development and growth strategies. His leadership is expected to enhance GE Digital's role in the upcoming energy company spin-off planned for 2024. Scott Strazik, CEO of GE's global energy business, expressed confidence in Reese's capabilities to drive digital transformation and decarbonization initiatives.
Model N, Inc. (NYSE: MODN) will announce its financial results for Q1 fiscal year 2022 on February 8, 2022, after market close. The company will host a conference call at 2:00 p.m. PT (5:00 p.m. ET) to discuss these results and provide a business outlook. Investors can access the call by dialing specific numbers or through a live webcast available on the Model N investor relations page. Model N specializes in cloud revenue management solutions, serving life sciences and high-tech companies worldwide.
Model N, Inc. (NYSE: MODN) announced its participation in Baird's Virtual Bus Tour on December 16, 2021, at 9:00 AM PT (12:00 PM ET). The event will be accessible via a live and replay webcast on the Model N investor relations page. As a leader in cloud revenue management solutions, Model N helps life sciences and high-tech companies enhance growth while minimizing revenue leakage. Trusted by major firms like Johnson & Johnson and AstraZeneca, Model N provides integrated solutions that automate pricing and compliance for profitable business scaling.
FAQ
What is the current stock price of MODEL N (MODN)?
What is the market cap of MODEL N (MODN)?
What does Model N, Inc. specialize in?
What are the main products offered by Model N?
Which industries does Model N serve?
What is the latest product launched by Model N?
What is Model N’s 2024 State of Revenue Report about?
Where does Model N generate most of its revenue?
Who are some of Model N’s notable clients?
What significant corporate event is Model N currently undergoing?
How does Model N address regulatory compliance for pharmaceuticals?
How can I learn more about Model N’s products and services?
